ArticleCurrent medicinal chemistry2024
Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome.
Ping Peng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it